Medicare Enrolled
Dr. Mark Tetz, M.D.
Family Medicine · Visalia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tetz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tetz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tetz
Dr. Mark Tetz is a family medicine specialist in Visalia, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tetz performed 4,624 Medicare services across 2,399 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tetz received a total of $12,694 from 66 pharmaceutical and/or device companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tetz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in CA
$12,694 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,624
Medicare services
Top 4% in CA for family medicine
2,399
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~231 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
593 | $86 | $136 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
396 | $119 | $192 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
202 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
190 | $72 | $95 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
190 | $80 | $87 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
170 | $132 | $147 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
167 | $3 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $50 | $97 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
133 | $6 | $7 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
119 | $10 | $13 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
118 | $2 | $3 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
113 | $281 | $335 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
113 | $31 | $33 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $10 | $15 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
57 | $42 | $50 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
57 | $128 | $150 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
56 | $48 | $73 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
40 | $29 | $51 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
32 | $34 | $45 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
24 | $9 | $16 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
16 | $169 | $174 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 11 | $20 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,694
Total received (2018-2024)
Avg $1,813/year across 7 years
Top 3% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
659
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,609 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,238
2023
$1,743
2022
$1,745
2021
$1,809
2020
$1,681
2019
$1,491
2018
$1,989
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$384
AstraZeneca Pharmaceuticals LP
$272
Lilly USA, LLC
$250
Axsome Therapeutics, Inc.
$206
Novo Nordisk Inc
$191
Boehringer Ingelheim Pharmaceuticals, Inc.
$176
Dynavax Technologies Corporation
$158
Merck Sharp & Dohme LLC
$85
PFIZER INC.
$84
Mylan Specialty L.P.
$66
Otsuka America Pharmaceutical, Inc.
$62
Astellas Pharma US Inc
$45
Phathom Pharmaceuticals, Inc.
$38
Amgen Inc.
$34
Seqirus USA Inc
$32
Verity Pharmaceuticals Inc.
$31
Ultragenyx Pharmaceutical Inc.
$24
VERTEX PHARMACEUTICALS INCORPORATED
$20
Daiichi Sankyo Inc.
$18
AIMMUNE THERAPEUTICS, INC.
$17
IDORSIA PHARMACEUTICALS US INC
$15
Antares Pharma, Inc.
$15
IRONWOOD PHARMACEUTICALS, INC
$13
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,460
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,095
AbbVie Inc.
$889
Amgen Inc.
$839
Lilly USA, LLC
$735
Merck Sharp & Dohme Corporation
$654
ABBVIE INC.
$631
Novo Nordisk Inc
$494
PFIZER INC.
$465
Amarin Pharma Inc.
$394
GlaxoSmithKline, LLC.
$337
Biohaven Pharmaceutical Holding Company Ltd.
$332
Bayer HealthCare Pharmaceuticals Inc.
$267
Kowa Pharmaceuticals America, Inc.
$250
Takeda Pharmaceuticals U.S.A., Inc.
$237
Biohaven Pharmaceuticals, Inc.
$230
SANOFI-AVENTIS U.S. LLC
$209
Axsome Therapeutics, Inc.
$206
IDORSIA PHARMACEUTICALS US INC
$172
Allergan, Inc.
$163
Dynavax Technologies Corporation
$158
Astellas Pharma US Inc
$153
Eisai Inc.
$153
Otsuka America Pharmaceutical, Inc.
$142
Merck Sharp & Dohme LLC
$132
Phadia US Inc.
$129
MannKind Corporation
$119
Supernus Pharmaceuticals, Inc.
$115
Mylan Specialty L.P.
$110
GENZYME CORPORATION
$108
ARBOR PHARMACEUTICALS, INC.
$93
Daiichi Sankyo Inc.
$78
Avanir Pharmaceuticals, Inc.
$76
Allergan Inc.
$71
Ultragenyx Pharmaceutical Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$63
Janssen Pharmaceuticals, Inc
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
AbbVie, Inc.
$51
Abbott Laboratories
$49
Shire North American Group Inc
$49
Phathom Pharmaceuticals, Inc.
$38
Optos, Inc.
$36
Teva Pharmaceuticals USA, Inc.
$34
Antares Pharma, Inc.
$34
Medtronic, Inc.
$34
Dexcom, Inc.
$33
Seqirus USA Inc
$32
Cranial Technologies, Inc
$32
Zyla Life Sciences, Inc.
$31
Verity Pharmaceuticals Inc.
$31
EUSA Pharma (US) LLC
$25
Genentech USA, Inc.
$22
Jazz Pharmaceuticals Inc.
$22
Esperion Therapeutics, Inc.
$21
VERTEX PHARMACEUTICALS INCORPORATED
$20
Sanofi Pasteur Inc.
$20
ITI, Inc.
$19
Circassia Pharmaceuticals Inc
$19
AIMMUNE THERAPEUTICS, INC.
$17
SANOFI PASTEUR INC.
$17
DEXCOM, INC.
$17
Arbor Pharmaceuticals, Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$13
Mannkind Corporation
$12
Sumitomo Pharma America, Inc.
$8
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · Auvelity · BELSOMRA · BREZTRI · BRILINTA · BYDUREON · CAPLYTA · CHANTIX · COMIRNATY · CREON · Crysvita · DEXCOM G6 TRANSMITTER · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · Doc Band · ELIQUIS · EMGALITY · EVENITY · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GEMTESA · Heplisav-B · Humira · INCRUSE · INJECTAFER · ImmunoCAP · JANUVIA · JARDIANCE · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LINZESS · LYRICA · Linzess · Livalo · MENACTRA · MOTEGRITY · MOUNJARO · MYDAYIS · MYRBETRIQ · Motegrity · NEXLETOL · NUEDEXTA · NURTEC ODT · OCT OPHTHALMOSCOPE · Otezla · Ozempic · PANORAMIC OPHTHALMOSCOPE · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · Prolia · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · SPRIX · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNJARDY · SYNTHROID · Sylvant · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tlando · Trintellix · UBRELVY · VAXELIS · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
211
Per 100K population
44.3
County median income
$69,489
Nearest hospital
KAWEAH HEALTH MEDICAL CENTER
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tetz is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tetz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Tetz performed 1,620 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tetz receive payments from pharmaceutical companies?
Yes. Dr. Tetz received a total of $12,694 from 66 companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tetz's costs compare to other family medicine physicians in Visalia?
Dr. Tetz's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tetz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Visalia
Browse family medicine physicians in Visalia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology